Cover Image

The urinary disposition of intravenously administered 11-nor-9-carboxy-delta-9-tetrahydrocannabinol in humans

The objective of this study was to investigate the fraction of an administered dose of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THCCOOH) that is actually excreted into urine and to determine its urinary half-life independent of the parent compound.

Saved in:
Bibliographic Details
Main Authors: Dietz, Lisa (Author) , Glaz-Sandberg, Anna (Author) , Nguyen, Thao-Hang (Author) , Skopp, Gisela (Author) , Mikus, Gerd (Author) , Aderjan, Rolf (Author)
Format: Article (Journal)
Language:English
Published: 2007
In: Therapeutic drug monitoring
Year: 2007, Volume: 29, Issue: 3, Pages: 368-372
ISSN:1536-3694
DOI:10.1097/FTD.0b013e31805ba6fd
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/FTD.0b013e31805ba6fd
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/drug-monitoring/Abstract/2007/06000/The_Urinary_Disposition_of_Intravenously.16.aspx
Get full text
Author Notes:Lisa Dietz, Anna Glaz-Sandberg, Hang Nguyen, Gisela Skopp, Gerd Mikus, Rolf Aderjan
Description
Summary:The objective of this study was to investigate the fraction of an administered dose of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THCCOOH) that is actually excreted into urine and to determine its urinary half-life independent of the parent compound.
Item Description:Gesehen am 08.12.2021
Physical Description:Online Resource
ISSN:1536-3694
DOI:10.1097/FTD.0b013e31805ba6fd

Similar Items